Smith-Magenis/Potocki-Lupski Syndromes, 17p11.2 Deletion/Duplication, FISH
Smith-Magenis syndrome (SMS) and Potocki-Lupski syndrome (PTLS) are reciprocal genomic disorders caused by non-allelic homologous recombination (NAHR) in the 17p11.2 region (~3.7 Mb). SMS results from deletion, while PTLS results from duplication of this critical region.
Both syndromes are characterized by intellectual disability, distinctive craniofacial features, developmental delay, sleep disturbance, and behavioral abnormalities. PTLS tends to present with comparatively milder cognitive impairment than SMS. Affected neonates often show delayed developmental milestones. Diagnosis can be confirmed by fluorescence in situ hybridization (FISH) using locus-specific probes targeting 17p11.2. This method detects both deletion and duplication events in the critical region.
- Confirms diagnosis of Smith-Magenis and Potocki-Lupski syndrome
- Assists in genetic counseling and family risk assessment
- Useful in screening at-risk neonates and family members
Positive (Deletion, SMS): Loss of probe signal indicating absence of 17p11.2 region.
Positive (Duplication, PTLS): Brighter or additional probe signals consistent with duplication.
Negative: Normal probe binding with signal intensity comparable to control.
Negative (no deletion or duplication detected)
Whole blood, Heparin/EDTA.
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: Unacceptable
Other acceptable specimens:
Fixed cell pellet, Amniotic fluid, Chorionic villi (none of the specimens should be frozen)
1-2 weeks.
- Am J Med Genet A. 2014 Feb;164A(2):500-4. [PMID: 24311450]
- J Korean Med Sci. 2012 Dec;27(12):1586–1590. [PMID: 23255863]
- Am J Hum Genet. 2007 Apr;80(4):633–649. [PMID: 17357070]
- Brain Dev. 2013 Aug;35(7):681-5. [PMID: 23078968]